The AI Revolution in Biopharma

"Generative AI" may be in the media spotlight, but the real breakthrough may lie in protein structure prediction (AlphaFold, ESMFold, ProGen, etc.). It is inevitable that the future of drug and therapeutic development will involve AI and ML computation for faster and more efficient simulations, replacing the slower trial-and-error method. Join us as executives across the biopharmaceutical sector discuss how ML computation is transforming drug and therapeutic discovery, development, and distribution.

[@avisekdeyati6505]

Insightful discussion on the impact of AL/ML on drug discovery! Thanks to recent development on AI, Synthetic Biology and Computation; we can engineer biology now. There are reasons to be optimistic that the process of drug discovery/development, its access and pricing will witness a paradigm shift in next couple of decades!